ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Rethinking Technology For Patients And Sites In Clinical Trials

  The solution to administrative burden in clinical trials is not in adding more tools, but in improved integration that allows software to fade into the background.

• Effective Use Of IRT In Decentralized And Hybrid Clinical Trials

  Uncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.

• Why Use Scorecards To Make Vendor Selection Decisions

  Scorecards enable structured, unbiased vendor selection by transforming complex clinical trial decisions into transparent, data-driven evaluations — ensuring operational excellence and regulatory compliance.

• Experts Discuss AI's Future In Pharma

  At the J.P. Morgan Health Conference, experts explored the transformative potential of artificial intelligence (AI) in drug development and deliberated on the essential requirements for ensuring positive outcomes in this evolving field.

• The Future Of Remote Patient Monitoring In Decentralized Clinical Trials

  Remote Patient Monitoring (RPM) is not just an innovation—it's a catalyst redefining how clinical research is conducted in the digital age.

• Build Versus Buy: What's The Best Tech Tool For Study Activation?

  In the case of study activation, there are several compelling reasons that buying an appropriate purpose-built system is a better choice than taking on the challenge of building a study activation tool.

• From Data Silos to Connected Intelligence: How AI Is Unifying Clinical Research Data

  AI tools like TrialKit AI revolutionize clinical trials by integrating diverse data sources, including wearables, breaking silos, enhancing insights, and enabling smarter, more patient-centered research.

• Reflexion Counts On Medrio To Launch First Studies

  Learn how a therapeutic oncology company was able to take advantage of an EDC system, establish a ePRO assessments collections platform, and receive guidance on data collection devices.

• Enhancing Competitive Intelligence In Pharma With Comprehensive Data Analysis

  Discover a unified platform that turns complex pharma data into clear, strategic insights, empowering teams to outpace competitors with evidence-backed decisions from pipeline to launch.

• Understanding Decentralized Clinical Trials: FDA vs. EMA Fundamentals

  Designing a global decentralized clinical trial requires understanding the differing FDA and EMA approaches to trial models and informed consent.